Eboo Pharmaceuticals

Eboo Pharmaceuticals is a private, development-stage biopharmaceutical company based in Durham, North Carolina. The company has focused on small-molecule therapeutics originating from chemistry and pharmacology research linked to the former Burroughs Wellcome laboratories in North Carolina. Its lead known programs, DPI-289 and DPI-290, are delta opioid receptor agonist and mu opioid receptor antagonist compounds being explored for Parkinson's disease and related dyskinesia-sparing use with levodopa. Publicly available information suggests the company has remained private and has concentrated on advancing preclinical assets through non-clinical proof-of-concept work while seeking funding and partnering opportunities. The company appears to be a niche CNS-focused biotech rather than a commercial-stage pharmaceutical business.